- Home
- ZJYL vs IMUX Comparison
ZJYL vs IMUX Comparison
Compare ZJYL & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZJYL
- IMUX
- Stock Information
- Founded
- ZJYL 2006
- IMUX 2016
- Country
- ZJYL China
- IMUX United States
- Employees
- ZJYL N/A
- IMUX N/A
- Industry
- ZJYL Industrial Specialties
- IMUX Biotechnology: Pharmaceutical Preparations
- Sector
- ZJYL Consumer Discretionary
- IMUX Health Care
- Exchange
- ZJYL Nasdaq
- IMUX Nasdaq
- Market Cap
- ZJYL 127.4M
- IMUX 102.2M
- IPO Year
- ZJYL 2023
- IMUX N/A
- Fundamental
- Price
- ZJYL $0.72
- IMUX $1.09
- Analyst Decision
- ZJYL
- IMUX Strong Buy
- Analyst Count
- ZJYL 0
- IMUX 7
- Target Price
- ZJYL N/A
- IMUX $12.67
- AVG Volume (30 Days)
- ZJYL 323.3K
- IMUX 555.7K
- Earning Date
- ZJYL 05-03-2025
- IMUX 05-07-2025
- Dividend Yield
- ZJYL N/A
- IMUX N/A
- EPS Growth
- ZJYL 18.46
- IMUX N/A
- EPS
- ZJYL 0.02
- IMUX N/A
- Revenue
- ZJYL $23,502,010.00
- IMUX N/A
- Revenue This Year
- ZJYL N/A
- IMUX N/A
- Revenue Next Year
- ZJYL N/A
- IMUX N/A
- P/E Ratio
- ZJYL $29.90
- IMUX N/A
- Revenue Growth
- ZJYL 18.57
- IMUX N/A
- 52 Week Low
- ZJYL $0.59
- IMUX $0.92
- 52 Week High
- ZJYL $4.65
- IMUX $2.11
- Technical
- Relative Strength Index (RSI)
- ZJYL 41.94
- IMUX 46.81
- Support Level
- ZJYL $0.66
- IMUX $1.18
- Resistance Level
- ZJYL $0.74
- IMUX $1.28
- Average True Range (ATR)
- ZJYL 0.09
- IMUX 0.07
- MACD
- ZJYL -0.02
- IMUX -0.00
- Stochastic Oscillator
- ZJYL 8.17
- IMUX 6.00
Stock Price Comparison Chart: ZJYL vs IMUX
About ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.